CONMED CORPORATION Proceeds from Lines of Credit
CONMED CORPORATION (CNMD) reported Proceeds from Lines of Credit of $595.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2026-07-29
- CONMED CORPORATION proceeds from lines of credit for the quarter ending 2025-12-31 was $187.00M, a 24.67% increase year-over-year.
- CONMED CORPORATION proceeds from lines of credit for the quarter ending 2025-09-30 was $167.00M, a 16.78% increase year-over-year.
- CONMED CORPORATION proceeds from lines of credit for the quarter ending 2025-06-30 was $175.43M, a 14.00% decline year-over-year.
- CONMED CORPORATION proceeds from lines of credit for the quarter ending 2025-03-31 was $166.00M, a 34.65% decline year-over-year.
- CONMED CORPORATION proceeds from lines of credit for fiscal 2025 was $695.43M, a 7.40% decline from fiscal 2024.
- CONMED CORPORATION proceeds from lines of credit for fiscal 2024 was $751.00M, a 8.53% increase from fiscal 2023.
- CONMED CORPORATION proceeds from lines of credit for fiscal 2023 was $692.00M, a 50.43% increase from fiscal 2022.
- CONMED CORPORATION proceeds from lines of credit for fiscal 2022 was $460.00M, a 40.78% increase from fiscal 2021.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 9 month as first filed | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $595.00M 10-Q · filed 2026-07-29 | ||||
| 2025-12-31 | $187.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $354.00M derived: sum of 2 quarters · filed 2026-02-17 | $529.43M derived: sum of 3 quarters · filed 2026-07-29 | $695.43M 10-K · filed 2026-02-17 | |
| 2025-09-30 | $167.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $342.43M derived: sum of 2 quarters · filed 2026-07-29 | $508.43M 10-Q · filed 2025-11-06 | $658.43M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-06-30 | $175.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $341.43M 10-Q · filed 2026-07-29 | $491.43M derived: sum of 3 quarters · filed 2026-07-29 | $634.43M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-03-31 | $166.00M 10-Q · filed 2025-05-01 | $316.00M derived: sum of 2 quarters · filed 2026-02-17 | $459.00M derived: sum of 3 quarters · filed 2026-02-17 | $663.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-12-31 | $150.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $293.00M derived: sum of 2 quarters · filed 2026-02-17 | $497.00M derived: sum of 3 quarters · filed 2026-02-17 | $751.00M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $143.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $347.00M derived: sum of 2 quarters · filed 2025-11-06 | $601.00M 10-Q · filed 2025-11-06 | $781.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-06-30 | $204.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $458.00M 10-Q · filed 2025-07-31 | $638.00M derived: sum of 3 quarters · filed 2026-02-17 | $819.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-03-31 | $254.00M 10-Q · filed 2025-05-01 | $434.00M derived: sum of 2 quarters · filed 2026-02-17 | $615.00M derived: sum of 3 quarters · filed 2026-02-17 | $773.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2023-12-31 | $180.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $361.00M derived: sum of 2 quarters · filed 2026-02-17 | $519.00M derived: sum of 3 quarters · filed 2026-02-17 | $692.00M 10-K · filed 2026-02-17 | |
| 2023-09-30 | $181.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $339.00M derived: sum of 2 quarters · filed 2024-10-31 | $512.00M 10-Q · filed 2024-10-31 | $655.00M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2023-06-30 | $158.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $331.00M 10-Q · filed 2024-08-01 | $474.00M derived: sum of 3 quarters · filed 2025-02-18 | $619.00M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2023-03-31 | $173.00M 10-Q · filed 2024-04-25 | $316.00M derived: sum of 2 quarters · filed 2025-02-18 | $461.00M derived: sum of 3 quarters · filed 2025-02-18 | $523.00M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2022-12-31 | $143.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $288.00M derived: sum of 2 quarters · filed 2025-02-18 | $350.00M derived: sum of 3 quarters · filed 2025-02-18 | $460.00M 10-K · filed 2025-02-18 | |
| 2022-09-30 | $145.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $207.00M derived: sum of 2 quarters · filed 2023-10-26 | $317.00M 10-Q · filed 2023-10-26 | $407.00M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $62.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $172.00M 10-Q · filed 2023-07-27 | $262.00M derived: sum of 3 quarters · filed 2024-02-28 | $359.75M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $110.00M 10-Q · filed 2023-04-27 | $200.00M derived: sum of 2 quarters · filed 2024-02-28 | $297.75M derived: sum of 3 quarters · filed 2024-02-28 | $372.75M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $90.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $187.75M derived: sum of 2 quarters · filed 2024-02-28 | $262.75M derived: sum of 3 quarters · filed 2024-02-28 | $326.75M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $97.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $172.75M derived: sum of 2 quarters · filed 2022-10-27 | $236.75M 10-Q · filed 2022-10-27 | $283.75M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-06-30 | $75.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $139.00M 10-Q · filed 2022-07-28 | $186.00M derived: sum of 3 quarters · filed 2023-02-21 | $230.00M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-03-31 | $64.00M 10-Q · filed 2022-05-05 | $111.00M derived: sum of 2 quarters · filed 2023-02-21 | $155.00M derived: sum of 3 quarters · filed 2023-02-21 | $204.00M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2020-12-31 | $47.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $91.00M derived: sum of 2 quarters · filed 2023-02-21 | $140.00M derived: sum of 3 quarters · filed 2023-02-21 | $199.00M 10-K · filed 2023-02-21 | |
| 2020-09-30 | $44.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $93.00M derived: sum of 2 quarters · filed 2021-10-28 | $152.00M 10-Q · filed 2021-10-28 | $174.00M derived: sum of 4 quarters · filed 2022-02-22 | |
| 2020-06-30 | $49.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $108.00M 10-Q · filed 2021-07-29 | $130.00M derived: sum of 3 quarters · filed 2022-02-22 | $157.00M derived: sum of 4 quarters · filed 2022-02-22 | |
| 2020-03-31 | $59.00M 10-Q · filed 2021-04-29 | $81.00M derived: sum of 2 quarters · filed 2022-02-22 | $108.00M derived: sum of 3 quarters · filed 2022-02-22 | $152.00M derived: sum of 4 quarters · filed 2022-02-22 | |
| 2019-12-31 | $22.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $49.00M derived: sum of 2 quarters · filed 2022-02-22 | $93.00M derived: sum of 3 quarters · filed 2022-02-22 | $392.00M 10-K · filed 2022-02-22 | |
| 2019-09-30 | $27.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $71.00M derived: sum of 2 quarters · filed 2020-10-29 | $370.00M 10-Q · filed 2020-10-29 | $419.00M derived: sum of 4 quarters · filed 2021-02-22 | |
| 2019-06-30 | $44.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $343.00M 10-Q · filed 2020-07-30 | $392.00M derived: sum of 3 quarters · filed 2021-02-22 | $439.00M derived: sum of 4 quarters · filed 2021-02-22 | |
| 2019-03-31 | $299.00M 10-Q · filed 2020-04-30 | $348.00M derived: sum of 2 quarters · filed 2021-02-22 | $395.00M derived: sum of 3 quarters · filed 2021-02-22 | $428.00M derived: sum of 4 quarters · filed 2021-02-22 | |
| 2018-12-31 | $49.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $96.00M derived: sum of 2 quarters · filed 2021-02-22 | $129.00M derived: sum of 3 quarters · filed 2021-02-22 | $153.00M 10-K · filed 2021-02-22 | |
| 2018-09-30 | $47.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $80.00M derived: sum of 2 quarters · filed 2019-10-31 | $104.00M 10-Q · filed 2019-10-31 | $144.00M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-06-30 | $33.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $57.00M 10-Q · filed 2019-08-01 | $97.00M derived: sum of 3 quarters · filed 2020-02-24 | $141.00M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-03-31 | $24.00M 10-Q · filed 2019-04-26 | $64.00M derived: sum of 2 quarters · filed 2020-02-24 | $108.00M derived: sum of 3 quarters · filed 2020-02-24 | $141.00M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2017-12-31 | $40.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $84.00M derived: sum of 2 quarters · filed 2020-02-24 | $117.00M derived: sum of 3 quarters · filed 2020-02-24 | $155.00M 10-K · filed 2020-02-24 | |
| 2017-09-30 | $44.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $77.00M derived: sum of 2 quarters · filed 2018-11-02 | $115.00M 10-Q · filed 2018-11-02 | $148.00M derived: sum of 4 quarters · filed 2019-02-25 | |
| 2017-06-30 | $33.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $71.00M 10-Q · filed 2018-08-02 | $104.00M derived: sum of 3 quarters · filed 2019-02-25 | $129.00M derived: sum of 4 quarters · filed 2019-02-25 | |
| 2017-03-31 | $38.00M 10-Q · filed 2018-04-26 | $71.00M derived: sum of 2 quarters · filed 2019-02-25 | $96.00M derived: sum of 3 quarters · filed 2019-02-25 | $126.00M derived: sum of 4 quarters · filed 2019-02-25 | |
| 2016-12-31 | $33.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $58.00M derived: sum of 2 quarters · filed 2019-02-25 | $88.00M derived: sum of 3 quarters · filed 2019-02-25 | $225.00M 10-K · filed 2019-02-25 | |
| 2016-09-30 | $25.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $55.00M derived: sum of 2 quarters · filed 2017-11-02 | $192.00M 10-Q · filed 2017-11-02 | $61.65M 10-Q · filed 2016-10-28 | $313.68M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $30.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $167.00M 10-Q · filed 2017-07-27 | $288.68M derived: sum of 3 quarters · filed 2018-02-26 | ||
| 2016-03-31 | $137.00M 10-Q · filed 2017-04-27 | $258.68M derived: sum of 2 quarters · filed 2018-02-26 | |||
| 2015-12-31 | $121.68M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $142.68M 10-K · filed 2018-02-26 | |||
| 2015-09-30 | $21.00M 10-Q · filed 2016-10-28 | ||||
| 2014-12-31 | $113.00M 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |